A. Akeson

发表

Structure and function of oxidation-reduction enzymes : proceedings of the Wenner-Gren symposium held at the Wenner-Gren Center, Stockholm, 23-27 August, 1970

A. Ehrenberg, A. Akeson, 1972 .

A fluorometric assay for the quantitation of cell adherence to endothelial cells.

A. Akeson, C. Woods, Ann L. Akeson, 1993, Journal of immunological methods.

D. McKean, R. Nemenoff, P. Jones, 2004, Circulation research.

Lymphangiogenesis in the developing lung promoted by VEGF-A.

A. Akeson, T. J. Mead, B. Mallory, 2006, Microvascular research.

Vascular Endothelial Growth Factor-A Induces Prenatal Neovascularization and Alters Bronchial Development in Mice

J. Whitsett, A. Akeson, J. Greenberg, 2005, Pediatric Research.

Suppressive effect of antioxidants on intercellular adhesion molecule-1 (ICAM-1) expression in human epidermal keratinocytes.

A. Akeson, C. Woods, M. Ikeda, 1994, The Journal of investigative dermatology.

Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease.

H. Gröne, B. Kaissling, M. Moeller, 2009, The American journal of pathology.

NFATc1 regulates lymphatic endothelial development

A. Akeson, Rishikesh M. Kulkarni, J. Greenberg, 2009, Mechanisms of Development.

Slit and robo expression in the developing mouse lung

J. Shannon, A. Akeson, J. Greenberg, 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

Suppression of interleukin-1 beta and LDL scavenger receptor expression in macrophages by a selective protein kinase C inhibitor.

C. J. Schmidt, A. Akeson, C. Woods, 1991, Journal of lipid research.

Inhibition of IL-1β expression in THP-1 cells by probucol and tocopherol

A. Akeson, R. Jackson, Craig E. Thomas, 1991 .

Lymphatic ontogeny and effect of hypoplasia in developing lung

M. Ikegami, A. Akeson, Amanda M. Herman, 2011, Mechanisms of Development.

Induction of interleukin 1 beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid.

A. Akeson, R. Jackson, Craig E. Thomas, 1992, The Journal of biological chemistry.

Mesenchymal expression of vascular endothelial growth factors D and A defines vascular patterning in developing lung

J. Shannon, A. Akeson, B. Mallory, 2002, Developmental dynamics : an official publication of the American Association of Anatomists.

Accessory cells induce a polyphosphatidylinositol response when cultured with mitogen‐activated T lymphocytes

A. Akeson, J. Harmony, B. M. McCarthy, 1990, Journal of cellular physiology.

AF12198, a Novel Low Molecular Weight Antagonist, Selectively Binds the Human Type I Interleukin (IL)-1 Receptor and Blocks in Vivo Responses to IL-1*

R. Barrett, B. Ackermann, A. Akeson, 1996, The Journal of Biological Chemistry.

Human aortic endothelial cells express the type I but not the type II receptor for interleukin‐1 (IL‐1)

A. Akeson, C. Woods, T. Bowlin, 1992, Journal of cellular physiology.

The selective activation of T8+ cells by neuraminidase and galactose oxidase is mediated by activated T4+ cells.

A. Akeson, J. Harmony, 1987, Experimental cell research.

The phosphatidylinositol response and proliferation of oxidative enzyme-activated human T lymphocytes: suppression by plasma lipoproteins.

A. Akeson, J. Harmony, D. W. Scupham, 1984, Journal of lipid research.

Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing.

J. Hutton, J. States, A. Akeson, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Mutant human adenosine deaminase alleles and their expression by transfection into fibroblasts.

J. Hutton, J. States, A. Akeson, 1988, The Journal of biological chemistry.

Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline.

Ronald W. Barrett, R. Barrett, H. Schreuder, 1995, European journal of biochemistry.

Temporal and spatial regulation of VEGF-A controls vascular patterning in the embryonic lung.

J. Whitsett, A. Akeson, Diane Wiginton, 2003, Developmental biology.

Complete sequence and structure of the gene for human adenosine deaminase.

D. J. Kaplan, J. Hutton, J. States, 1986, Biochemistry.

Formation and Radiosensitivity of Myoglobin

A. Akeson, R. Bonnichsen, G. Hevesy, 1955, Nature.

In vitro model for developmental progression from vasculogenesis to angiogenesis with a murine endothelial precursor cell line, MFLM-4.

A. Akeson, J. Greenberg, F. Thompson, 2001, Microvascular research.

Embryonic vasculogenesis by endothelial precursor cells derived from lung mesenchyme

A. Akeson, J. Greenberg, H. Paradis, 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice.

J. Whitsett, K. Albertine, T. L. Le Cras, 2004, American journal of physiology. Lung cellular and molecular physiology.

Normal and mutant human adenosine deaminase genes

J. Hutton, A. Akeson, D. Wiginton, 1989, Journal of cellular biochemistry.

Endothelial cell activation in a VEGF-A gradient: relevance to cell fate decisions.

A. Akeson, Amanda M. Herman, Diane Wiginton, 2010, Microvascular research.

High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries.

J. H. Butler, E. Whitehorn, E. Tate, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Brain pyruvate kinase activity in PKU model systems

C. Vorhees, A. Akeson, R. L. Brunner, 1979, Journal of neurochemistry.

A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist

Ronald W. Barrett, R. Barrett, H. Schreuder, 1997, Nature.

Crystals of soluble interleukin‐1 receptor complexed with its natural antagonist reveal a 1:1 receptor‐ligand complex

R. Barrett, A. Soffientini, A. Akeson, 1995, FEBS letters.

Human IL-1 receptor antagonist from Escherichia coli: large-scale microbial growth and protein purification.

A. Soffientini, C. Sottani, A. Akeson, 1998, Journal of biotechnology.

Application of conformationally restricted peptidomimetics to modeling the bound conformation of peptide antagonists with the IL-1 receptor

J. A. Malikayil, H. Schreuder, A. Akeson, 1998, Letters in Peptide Science.

Identification of a specific receptor for interleukin-1 in vascular smooth muscle cells: regulation by interleukin-1 and interleukin-6.

A. Akeson, J. F. French, R. C. Dage, 1993, European journal of pharmacology.

Overexpression of Vascular Endothelial Growth Factor in the Germinal Matrix Induces Neurovascular Proteases and Intraventricular Hemorrhage

E. Huang, C. Kuan, R. Dunn, 2013, Science Translational Medicine.

An ex vivo method for studying inflammation in cynomolgus monkeys: analysis of interleukin-1 receptor antagonist.

B. Seligmann, J. Robinson, A. Akeson, 1996, Journal of pharmacological and toxicological methods.